These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36001142)

  • 61. Clinical features of patients with Myasthenia gravis from the Henan province, China.
    Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
    Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of patients with ocular myasthenia gravis - A case series.
    Karni A; Asmail A; Drory VE; Kolb H; Kesler A
    eNeurologicalSci; 2016 Sep; 4():30-33. PubMed ID: 29430546
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ocular myasthenia gravis: controversies and updates.
    Wong SH; Huda S; Vincent A; Plant GT
    Curr Neurol Neurosci Rep; 2014 Jan; 14(1):421. PubMed ID: 24272275
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxidative modifications of blood serum proteins in myasthenia gravis.
    Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
    J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
    Ma R; Cheng Y; Gan L; Zhou X; Qian J
    BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SFEMG in ocular myasthenia gravis diagnosis.
    Padua L; Stalberg E; LoMonaco M; Evoli A; Batocchi A; Tonali P
    Clin Neurophysiol; 2000 Jul; 111(7):1203-7. PubMed ID: 10880794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ocular Myasthenia Gravis: Toward a Risk of Generalization Score and Sample Size Calculation for a Randomized Controlled Trial of Disease Modification.
    Wong SH; Petrie A; Plant GT
    J Neuroophthalmol; 2016 Sep; 36(3):252-8. PubMed ID: 27031125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autoimmunity in ocular and generalised myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT; Lawton J; Luciani G; McLeod J; Bradley J; Genkins G; Teng CS
    J Neuroimmunol; 1981 Sep; 1(3):325-32. PubMed ID: 7334085
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunosuppressive treatment of ocular myasthenia gravis.
    Tackenberg B; Hemmer B; Oertel WH; Sommer N
    BioDrugs; 2001; 15(6):369-78. PubMed ID: 11520248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term outcome of 424 childhood-onset myasthenia gravis patients.
    Gui M; Luo X; Lin J; Li Y; Zhang M; Zhang X; Yang M; Wang W; Bu B
    J Neurol; 2015; 262(4):823-30. PubMed ID: 25588729
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Ocular myasthenia: a diagnostic and management challenge--a review].
    Langmann A; Lindner S; Koch M; Diez J
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ocular myasthenia gravis: an update on diagnosis and treatment.
    Fortin E; Cestari DM; Weinberg DH
    Curr Opin Ophthalmol; 2018 Nov; 29(6):477-484. PubMed ID: 30281029
    [TBL] [Abstract][Full Text] [Related]  

  • 74. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis.
    Wang ZY; Diethelm-Okita B; Okita DK; Kaminski HJ; Howard JF; Conti-Fine BM
    J Neuroimmunol; 2000 Aug; 108(1-2):29-39. PubMed ID: 10900334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Single fiber electromyography in the diagnosis of ocular myasthenia gravis: report of 90 cases.
    Cui LY; Guan YZ; Wang H; Tang XF
    Chin Med J (Engl); 2004 Jun; 117(6):848-51. PubMed ID: 15198885
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
    Popperud TH; Boldingh MI; Rasmussen M; Kerty E
    Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis.
    Ahn J; Park KS; Kim JS; Hwang JM
    J Clin Neurol; 2018 Jul; 14(3):333-338. PubMed ID: 29856158
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years.
    Huang X; Liu WB; Men LN; Feng HY; Li Y; Luo CM; Qiu L
    Neurol Sci; 2013 Jun; 34(6):911-7. PubMed ID: 22806326
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis.
    Mee J; Paine M; Byrne E; King J; Reardon K; O'Day J
    J Neuroophthalmol; 2003 Dec; 23(4):251-5. PubMed ID: 14663303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.